Global Scleroderma Therapeutics Market 2022-2026

PUBLISHED: March 2, 2022

PAGES: 120 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Technavio has been monitoring the scleroderma therapeutics market and it is poised to grow by $ 573.87 mn during 2022-2026, progressing at a CAGR of 5.44% during the forecast period. Our report on the scleroderma therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high unmet medical needs, rising focus on awareness-raising initiatives, and increased funding for R and D activities. In addition, high unmet medical needs are anticipated to boost the growth of the market as well.

The scleroderma therapeutics market analysis includes disease segment and geographic landscape.

Technavio's scleroderma therapeutics market is segmented as below:

By Disease Type

Localized Scleroderma
Systemic Scleroderma

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the introduction of stem cell therapy in scleroderma treatment as one of the prime reasons driving the scleroderma therapeutics market growth during the next few years. Also, the advent of novel therapies, partnerships, and strategic alliances will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the scleroderma therapeutics market covers the following areas:

Scleroderma therapeutics market sizing
Scleroderma therapeutics market forecast
Scleroderma therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading scleroderma therapeutics market vendors that include AbbVie Inc., Akashi Therapeutics, Amneal Pharmaceuticals Inc., Antares Pharma Inc., Argentis Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Castle Creek Biosciences Inc., Chemomab Therapeutics Ltd., Corbus Pharmaceuticals Holdings Inc., Cumberland Pharmaceuticals Inc., Emerald Health Pharmaceuticals, F. Hoffmann La Roche Ltd., Kadmon Holdings Inc., Medexus Pharmaceuticals Inc., Novartis AG, Pfizer Inc., and The Procter and Gamble Co. Also, the scleroderma therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR72388

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Disease Type

5.1 Market segments
Exhibit 24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Disease Type - Market share 2021-2026 (%)
5.2 Comparison by Disease Type
Exhibit 26: Chart on Comparison by Disease Type
Exhibit 27: Data Table on Comparison by Disease Type
5.3 Localized scleroderma - Market size and forecast 2021-2026
Exhibit 28: Chart on Localized scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Localized scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Localized scleroderma - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Localized scleroderma - Year-over-year growth 2021-2026 (%)
5.4 Systemic scleroderma - Market size and forecast 2021-2026
Exhibit 32: Chart on Systemic scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Systemic scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Systemic scleroderma - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Systemic scleroderma - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Disease Type
Exhibit 36: Market opportunity by Disease Type ($ million)

6 Customer Landscape

6.1 Customer landscape overview
Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

7.1 Geographic segmentation
Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 40: Chart on Geographic comparison
Exhibit 41: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 Canada - Market size and forecast 2021-2026
Exhibit 58: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.8 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.9 Denmark - Market size and forecast 2021-2026
Exhibit 66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 India - Market size and forecast 2021-2026
Exhibit 74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on India - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 79: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape

9.1 Overview
9.2 Vendor landscape
Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 81: Overview on factors of disruption
9.4 Industry risks
Exhibit 82: Impact of key risks on business

10 Vendor Analysis

10.1 Vendors covered
Exhibit 83: Vendors covered
10.2 Market positioning of vendors
Exhibit 84: Matrix on vendor position and classification
10.3 Akashi Therapeutics
Exhibit 85: Akashi Therapeutics - Overview
Exhibit 86: Akashi Therapeutics - Product / Service
Exhibit 87: Akashi Therapeutics - Key offerings
10.4 Argentis Pharmaceuticals LLC
Exhibit 88: Argentis Pharmaceuticals LLC - Overview
Exhibit 89: Argentis Pharmaceuticals LLC - Product / Service
Exhibit 90: Argentis Pharmaceuticals LLC - Key offerings
10.5 Boehringer Ingelheim International GmbH
Exhibit 91: Boehringer Ingelheim International GmbH - Overview
Exhibit 92: Boehringer Ingelheim International GmbH - Business segments
Exhibit 93: Boehringer Ingelheim International GmbH - Key news
Exhibit 94: Boehringer Ingelheim International GmbH - Key offerings
Exhibit 95: Boehringer Ingelheim International GmbH - Segment focus
10.6 Bristol-Myers Squibb Co.
Exhibit 96: Bristol-Myers Squibb Co. - Overview
Exhibit 97: Bristol-Myers Squibb Co. - Product / Service
Exhibit 98: Bristol-Myers Squibb Co. - Key offerings
10.7 Castle Creek Biosciences Inc.
Exhibit 99: Castle Creek Biosciences Inc. - Overview
Exhibit 100: Castle Creek Biosciences Inc. - Product / Service
Exhibit 101: Castle Creek Biosciences Inc. - Key offerings
10.8 Chemomab Therapeutics Ltd.
Exhibit 102: Chemomab Therapeutics Ltd. - Overview
Exhibit 103: Chemomab Therapeutics Ltd. - Business segments
Exhibit 104: Chemomab Therapeutics Ltd. - Key offerings
Exhibit 105: Chemomab Therapeutics Ltd. - Segment focus
10.9 Corbus Pharmaceuticals Holdings Inc.
Exhibit 106: Corbus Pharmaceuticals Holdings Inc. - Overview
Exhibit 107: Corbus Pharmaceuticals Holdings Inc. - Business segments
Exhibit 108: Corbus Pharmaceuticals Holdings Inc. - Key offerings
Exhibit 109: Corbus Pharmaceuticals Holdings Inc. - Segment focus
10.10 Emerald Health Pharmaceuticals
Exhibit 110: Emerald Health Pharmaceuticals - Overview
Exhibit 111: Emerald Health Pharmaceuticals - Business segments
Exhibit 112: Emerald Health Pharmaceuticals - Key offerings
Exhibit 113: Emerald Health Pharmaceuticals - Segment focus
10.11 F. Hoffmann La Roche Ltd.
Exhibit 114: F. Hoffmann La Roche Ltd. - Overview
Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 116: F. Hoffmann La Roche Ltd. - Key news
Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus
10.12 Kadmon Holdings Inc.
Exhibit 119: Kadmon Holdings Inc. - Overview
Exhibit 120: Kadmon Holdings Inc. - Product / Service
Exhibit 121: Kadmon Holdings Inc. - Key offerings

11 Appendix

11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 122: Inclusions checklist
Exhibit 123: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 124: Currency conversion rates for US$
11.4 Research methodology
Exhibit 125: Research methodology
Exhibit 126: Validation techniques employed for market sizing
Exhibit 127: Information sources
11.5 List of abbreviations
Exhibit 128: List of abbreviations

Exhibits

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Disease Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Disease Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Disease Type
Exhibits27: Data Table on Comparison by Disease Type
Exhibits28: Chart on Localized scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Localized scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Localized scleroderma - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Localized scleroderma - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Systemic scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Systemic scleroderma - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Systemic scleroderma - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Systemic scleroderma - Year-over-year growth 2021-2026 (%)
Exhibits36: Market opportunity by Disease Type ($ million)
Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits40: Chart on Geographic comparison
Exhibits41: Data Table on Geographic comparison
Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Denmark - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Denmark - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits78: Market opportunity By Geographical Landscape ($ million)
Exhibits79: Impact of drivers and challenges in 2021 and 2026
Exhibits80: Overview on Criticality of inputs and Factors of differentiation
Exhibits81: Overview on factors of disruption
Exhibits82: Impact of key risks on business
Exhibits83: Vendors covered
Exhibits84: Matrix on vendor position and classification
Exhibits85: Akashi Therapeutics - Overview
Exhibits86: Akashi Therapeutics - Product / Service
Exhibits87: Akashi Therapeutics - Key offerings
Exhibits88: Argentis Pharmaceuticals LLC - Overview
Exhibits89: Argentis Pharmaceuticals LLC - Product / Service
Exhibits90: Argentis Pharmaceuticals LLC - Key offerings
Exhibits91: Boehringer Ingelheim International GmbH - Overview
Exhibits92: Boehringer Ingelheim International GmbH - Business segments
Exhibits93: Boehringer Ingelheim International GmbH - Key news
Exhibits94: Boehringer Ingelheim International GmbH - Key offerings
Exhibits95: Boehringer Ingelheim International GmbH - Segment focus
Exhibits96: Bristol-Myers Squibb Co. - Overview
Exhibits97: Bristol-Myers Squibb Co. - Product / Service
Exhibits98: Bristol-Myers Squibb Co. - Key offerings
Exhibits99: Castle Creek Biosciences Inc. - Overview
Exhibits100: Castle Creek Biosciences Inc. - Product / Service
Exhibits101: Castle Creek Biosciences Inc. - Key offerings
Exhibits102: Chemomab Therapeutics Ltd. - Overview
Exhibits103: Chemomab Therapeutics Ltd. - Business segments
Exhibits104: Chemomab Therapeutics Ltd. - Key offerings
Exhibits105: Chemomab Therapeutics Ltd. - Segment focus
Exhibits106: Corbus Pharmaceuticals Holdings Inc. - Overview
Exhibits107: Corbus Pharmaceuticals Holdings Inc. - Business segments
Exhibits108: Corbus Pharmaceuticals Holdings Inc. - Key offerings
Exhibits109: Corbus Pharmaceuticals Holdings Inc. - Segment focus
Exhibits110: Emerald Health Pharmaceuticals - Overview
Exhibits111: Emerald Health Pharmaceuticals - Business segments
Exhibits112: Emerald Health Pharmaceuticals - Key offerings
Exhibits113: Emerald Health Pharmaceuticals - Segment focus
Exhibits114: F. Hoffmann La Roche Ltd. - Overview
Exhibits115: F. Hoffmann La Roche Ltd. - Business segments
Exhibits116: F. Hoffmann La Roche Ltd. - Key news
Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits119: Kadmon Holdings Inc. - Overview
Exhibits120: Kadmon Holdings Inc. - Product / Service
Exhibits121: Kadmon Holdings Inc. - Key offerings
Exhibits122: Inclusions checklist
Exhibits123: Exclusions checklist
Exhibits124: Currency conversion rates for US$
Exhibits125: Research methodology
Exhibits126: Validation techniques employed for market sizing
Exhibits127: Information sources
Exhibits128: List of abbreviations